Suppr超能文献

对接受口服抗凝治疗的患者进行药物安全知识教育:一项全科医疗中的整群随机研究。

Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice.

作者信息

Vormfelde Stefan Viktor, Abu Abed Manar, Hua Thanh Duc, Schneider Simon, Friede Tim, Chenot Jean-François

机构信息

Department of Clinical Pharmacology, University Medical Center Göttingen, Department of General Practice, University Medical Center Göttingen, Department of Medical Statistics University Medical Center Göttingen, Institute for Community Medicine, Section General Practice and Family Medicine, University of Greifswald.

出版信息

Dtsch Arztebl Int. 2014 Sep 12;111(37):607-14. doi: 10.3238/arztebl.2014.0607.

Abstract

BACKGROUND

Orally anticoagulated patients with insufficient knowledge about their treatment have a higher risk of complications. Standardized patient education could raise their level of knowledge and improve time spent within target INR range.

METHODS

This cluster randomized trial included 319 anticoagulated patients drawn from 22 general medical practices. 185 patients received patient education, conducted by practice nurses, consisting of a video, a brochure, and a questionnaire; 134 control patients received only the brochure. The primary endpoint was knowledge about treatment six months after the patient education session. The secondary endpoints were time in the INR (international normalized ratio) target range and complications of anticoagulation.

RESULTS

Patients in the intervention and control groups were of comparable mean age (73 vs. 72 years). They answered a comparable number of questions correctly before the intervention (6.8 ± 0.2 vs. 6.7 ± 0.2) but differed significantly on this measure at six months (9.9 ± 0.2 vs. 7.6 ± 0.2, mean difference 2.3 questions, 95% confidence interval [CI] 1.5-3.1, p< 0.001). In the six months prior to the intervention, the INR was in the target range 65 ± 2% vs. 66 ± 3% of the time; in the six months afterward, 71 ± 1% vs. 64 ± 3% of the time (mean difference 7 percentage points, 95% CI -2 to -16 percentage points, p = 0.11). The complication rates were comparable in the two groups (12% vs. 16%, p = 0.30). Patients in the intervention group approved of patient education sessions to a greater extent than control patients (87% vs. 56%).

CONCLUSION

Patient education was found to be practical, to improve knowledge relating to patient safety in a durable manner, and to meet with the approval of the patients who received it. There was a statistically non-significant trend toward an improvement of the time spent in the INR target range. In view of the major knowledge deficits of orally anticoagulated patients, standardized patient education ought to be made a part of their routine care.

摘要

背景

口服抗凝治疗的患者若对其治疗了解不足,则并发症风险更高。标准化的患者教育可提高他们的知识水平,并改善处于国际标准化比值(INR)目标范围内的时间。

方法

这项整群随机试验纳入了来自22家普通医疗诊所的319名接受抗凝治疗的患者。185名患者接受了由执业护士开展的患者教育,内容包括一段视频、一本宣传册和一份问卷;134名对照患者仅收到了宣传册。主要终点是患者教育课程结束六个月后对治疗的了解情况。次要终点是处于INR(国际标准化比值)目标范围内的时间以及抗凝治疗的并发症。

结果

干预组和对照组患者的平均年龄相当(分别为73岁和72岁)。在干预前,他们正确回答的问题数量相当(分别为6.8±0.2个和6.7±0.2个),但在六个月时,这一指标存在显著差异(分别为9.9±0.2个和7.6±0.2个,平均差异为2.3个问题,95%置信区间[CI]为1.5 - 3.1,p<0.001)。在干预前的六个月中,INR处于目标范围内的时间分别为65±2%和66±3%;在干预后的六个月中,这一比例分别为71±1%和64±3%(平均差异为7个百分点,95%CI为 - 2至 - 16个百分点,p = 0.11)。两组的并发症发生率相当(分别为12%和16%,p = 0.30)。干预组患者比对照组患者更认可患者教育课程(分别为87%和56%)。

结论

发现患者教育切实可行,能持久改善与患者安全相关的知识,并得到了接受教育患者的认可。在INR目标范围内的时间有改善的趋势,但在统计学上无显著意义。鉴于口服抗凝治疗患者存在重大的知识缺陷,标准化的患者教育应成为他们常规护理的一部分。

相似文献

引用本文的文献

2
The Impact of a Pharmacist-led Warfarin Educational Video in a Saudi Setting.药剂师主导的华法林教育视频在沙特背景下的影响。
J Pharm Bioallied Sci. 2020 Oct-Dec;12(4):413-422. doi: 10.4103/jpbs.JPBS_188_20. Epub 2020 Oct 8.
9
Health literacy and knowledge in a cohort of Australian patients taking warfarin.一组服用华法林的澳大利亚患者的健康素养与知识水平
Pharm Pract (Granada). 2018 Jan-Mar;16(1):1080. doi: 10.18549/PharmPract.2018.01.1080. Epub 2018 Mar 24.
10
Disease understanding in patients newly diagnosed with atrial fibrillation.心房颤动初诊患者的疾病认知。
Heart. 2018 Mar;104(6):494-501. doi: 10.1136/heartjnl-2017-311800. Epub 2017 Aug 8.

本文引用的文献

1
Self-management of oral anticoagulation.口服抗凝药的自我管理。
Dtsch Arztebl Int. 2014 Feb 7;111(6):83-91. doi: 10.3238/arztebl.2014.0083.
3
A randomized trial of genotype-guided dosing of warfarin.华法林基因指导剂量的随机试验。
N Engl J Med. 2013 Dec 12;369(24):2294-303. doi: 10.1056/NEJMoa1311386. Epub 2013 Nov 19.
6
Novel oral anticoagulants in cardiovascular disease.心血管疾病中的新型口服抗凝剂。
J Cardiovasc Pharmacol Ther. 2014 Jan;19(1):34-44. doi: 10.1177/1074248413501392. Epub 2013 Sep 13.
9
Assessing bleeding risk in patients taking anticoagulants.评估服用抗凝药物患者的出血风险。
J Thromb Thrombolysis. 2013 Apr;35(3):312-9. doi: 10.1007/s11239-013-0899-7.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验